Clinical trials

3

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

VDyne Transcatheter Tricuspid Valve Replacement Study to Evaluate Safety and Clinical Efficacy in Patients With Symptomatic Severe Tricuspid Valve Regurgitation (TRIVITA Pivotal Trial)

Pivotal trial to evaluate the safety and clinical efficacy of the VDyne System for the treatment of symptomatic severe or greater tricuspid regurgitation.

Participants needed: 730
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: VDyne, Inc.Updated: Apr 8, 2026
Eligibility criteria

Age ≥18 years old [+7]

Subject unable or unwilling to comply with study required testing and follow-up... [+17]

Status: Recruiting

Clinical Safety and Efficacy of the VDyne Transcatheter Tricuspid Valve Replacement System for the Treatment of Tricuspid Regurgitation ( VISTA-US)

The purpose of this clinical study is to evaluate the safety and clinical efficacy of the VDyne System in the treatment of symptomatic severe tricuspid regurgitation (TR).

Participants needed: 30
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: VDyne, Inc.Updated: Mar 31, 2026Locations: 11
Eligibility criteria

Symptomatic severe tricuspid valve regurgitation of primary or secondary etiolog... [+6]

Patient anatomy (cardiac and vascular) is not suitable for VDyne System as asses... [+38]

Status: Recruiting

Clinical Safety and Efficacy of the VDyne Transcatheter Tricuspid Valve Replacement System for the Treatment of Tricuspid Regurgitation

The purpose of this clinical study is to collect safety and efficacy data of the VDyne System to support Conformitè Europëenne (CE) Mark of the VDyne System.

Participants needed: 120
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: VDyne, Inc.Updated: Nov 3, 2025Locations: 21
Eligibility criteria

Severe or greater tricuspid valve regurgitation of primary or secondary etiology... [+5]

Patient anatomy (cardiac and vascular) is not suitable for the VDyne System as a... [+38]